JPRN-UMIN000017138
Completed
未知
Phase II trial of dose dense paclitaxel plus carboplatin in advanced or recurrent uterine corpus cancer - KCOG-G-1301 trial
Kansai Clinical Oncology Group0 sites48 target enrollmentApril 20, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Advanced or recurrent uterine corpus cancer
- Sponsor
- Kansai Clinical Oncology Group
- Enrollment
- 48
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)motor or sensory neuropathy with dysfunction 2\) alcoholic hypersensitivity 3\)bacterial infection to needtreatment 4\) myocardial infarction within 6 months 5\) unstable angina 6\) poor control diabetes 7\) active multiple malignancy 8\) Interstitial pneumonia, pulmonary fibrosis 9\) Paclitaxel or CBDCA is contra\-indicated. 10\) HBs\-Ag(\+) 11\) Paralytic or mechanical bowel obstruction 12\) History of severe drug\-induced hypersensitivity syndrome 13\) Any other cases who are regarded as inadequate for study enrollment by investigators.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II trial of Combination with Paclitaxel, Carboplatin and Cetuximab (PCE) as a first line treatment in patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckJPRN-UMIN000010507CSPOR-HN 02 executive committee45
Completed
Phase 2
A randomized phase II study of paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV non-squamous-non-small cell lung cancer: NVALT12non-small cell lung cancer10029107NL-OMON36516Stichting NVALT studies222
Active, not recruiting
Not Applicable
A randomized phase II study of paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV non-squamous-non-small cell lung cancer: NVALT12 - NVALT12metastatic non-squamous non-small-cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVEUCTR2010-022104-50-NLStichting NVALT Studies222
Recruiting
Phase 2
Phase 2 study of dose-dense nab-paclitaxel followed by EC as neoadjuvant chemotherapy for HER2-negative breast cancerHER2-negative primary breast cancerJPRN-UMIN000026143Teikyo University School of Medicine50
Completed
Not Applicable
RCT PhaseII trial of Paclitaxel (P) and Carboplatin (C) plus continuous Gemcitabine (G) versus Gemcitabine (G) and Carboplatin (C) plus continuous Gemcitabine in untreated non-small cell lung cancer (NSCLC)on-small cell lung cancerJPRN-UMIN000008252Respiratory, Osaka University Hospital100